Cargando...
Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
OBJECTIVE: Radium-223(223Ra) is indicated for patients (p) with metastatic castration resistant prostate cancer (mCRCP). OBJECTIVES: The aim of this study was to evaluate the role of baseline clinical variables associated with overall survival (OS) and toxicity of 223Ra. Its purpose was to identify...
Guardado en:
| Publicado en: | Int Braz J Urol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Sociedade Brasileira de Urologia
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7239273/ https://ncbi.nlm.nih.gov/pubmed/32213206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1677-5538.IBJU.2019.0343 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|